DCF — LANKENAU MEDICAL CENTER
Enterprise Value: $-1.5B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-1.5B
Enterprise Value
$-476.3M
PV of Cash Flows
$-1.1B
PV of Terminal Value
$-1.7B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $640.2M | $-101.9M | -16.0% | $-129.0M | $-117.2M |
| Year 2 | $659.4M | $-98.3M | -15.0% | $-126.2M | $-104.3M |
| Year 3 | $679.2M | $-94.5M | -14.0% | $-123.2M | $-92.6M |
| Year 4 | $699.6M | $-93.8M | -13.0% | $-123.4M | $-84.3M |
| Year 5 | $720.6M | $-94.8M | -13.0% | $-125.3M | $-77.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-1.5B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$621.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.16409610635132407
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5